Why the study?
Despite evidence-based guidelines, VTE prophylaxis remains under-used in medically ill patients due to ambiguity regarding patient selection, agent selection, duration, and bleeding risks.
How should VTE prophylaxis be appropriately selected and managed in acutely ill medical patients?
Population
Acutely ill medical patients
Design
Review
Authors
Loading...
Validated risk models may guide inpatient prophylaxis selection; extended post-discharge use leaves open benefit pending trials.
How should VTE prophylaxis be appropriately selected and managed in acutely ill medical patients?
This review emphasizes the use of validated risk assessment models to balance VTE and bleeding risks for appropriate inpatient prophylaxis, while advising against routine post-discharge extension.
Skeik et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: